FIELD: medicine.
SUBSTANCE: invention relates to a method of producing radionuclide 177Lu without a carrier for use in nuclear medicine. Method comprises irradiating target containing 176Yb, neutron flux in nuclear reactor, in irradiation by reaction 176Yb(n,γ)I77Yb (1.9 h) β-→I77Lu in target creates target isotope 177Lu, which is then separated from ytterbium, first depositing ytterbium in the form of ytterbium sulphate by contacting the ytterbium sulphate solution and 177Lu and sodium amalgams, while stirring and dropping amalgam, with cleaning solution from precipitate, after that, translating 177Lu and the remaining ytterbium in the acetic acid solution and performing successive contact reduction operations with drop-by-drop supply of amalgam and mixing to reduce loss of lutetium, a low-boiling solvent which is immiscible with working solutions is added to the cell.
EFFECT: obtaining isotope 177Lu in practically significant amounts (tens of curies) when using nuclear reactors with average neutron flux of ~1014 n⋅cm-2⋅c-1.
4 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING A RADIONUCLIDE OF LUTETIUM-177 | 2016 |
|
RU2624636C1 |
METHOD OF PRODUCING LUTETIUM-177 RADIOISOTOPE | 2013 |
|
RU2542733C1 |
METHOD OF PRODUCING RADIONUCLIDE Lu-177 | 2019 |
|
RU2704005C1 |
METHOD OF OBTAINING RADIONUCLIDE LUTETIUM-177 | 2015 |
|
RU2594020C1 |
METHOD FOR ISOLATION OF LUTETIUM-177 FROM IRRADIATED YTTERBIUM | 2022 |
|
RU2795790C1 |
METHOD OF PRODUCING CARRIER-FREE HIGH-PURITY Lu COMPOUNDS AND CARRIER-FREE Lu COMPOUNDS | 2012 |
|
RU2573475C2 |
METHOD OF PRODUCING PHARMACEUTICAL SUBSTANCE BASED ON LUTETIUM-177 FROM YTTERBIUM-176 IRRADIATED IN NEUTRON FLUX | 2023 |
|
RU2823124C1 |
METHOD OF SEPARATING LUTETIUM AND YTTERBIUM BY CHROMATOGRAPHY | 2020 |
|
RU2741009C1 |
METHOD FOR EXTRACTION OF YTTERBIUM ISOTOPE | 2006 |
|
RU2390375C2 |
RADIONUCLIDE GENERATOR HAVING FIRST AND SECOND ATOMS OF THE FIRST ELEMENT | 2012 |
|
RU2630475C2 |
Authors
Dates
2019-07-25—Published
2018-11-26—Filed